DK0631776T3 - Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser - Google Patents

Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser

Info

Publication number
DK0631776T3
DK0631776T3 DK94401460T DK94401460T DK0631776T3 DK 0631776 T3 DK0631776 T3 DK 0631776T3 DK 94401460 T DK94401460 T DK 94401460T DK 94401460 T DK94401460 T DK 94401460T DK 0631776 T3 DK0631776 T3 DK 0631776T3
Authority
DK
Denmark
Prior art keywords
beta
endothelial cells
synthetases
accelerate
inhibit
Prior art date
Application number
DK94401460T
Other languages
Danish (da)
English (en)
Inventor
Christian Bloy
Jean-Pierre Cazenave
Bernard Hercelin
Bernard Teisseire
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0631776T3 publication Critical patent/DK0631776T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94401460T 1993-07-02 1994-06-28 Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser DK0631776T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308111A FR2707494B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
DK0631776T3 true DK0631776T3 (da) 2001-03-05

Family

ID=9448827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94401460T DK0631776T3 (da) 1993-07-02 1994-06-28 Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser

Country Status (13)

Country Link
US (1) US5478821A (de)
EP (1) EP0631776B1 (de)
JP (1) JP3993647B2 (de)
AT (1) ATE197668T1 (de)
CA (1) CA2127214C (de)
DE (1) DE69426316T2 (de)
DK (1) DK0631776T3 (de)
ES (1) ES2154285T3 (de)
FR (1) FR2707494B1 (de)
GR (1) GR3035059T3 (de)
HU (1) HU214716B (de)
PT (1) PT631776E (de)
RU (1) RU2131246C1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2238074T3 (es) * 1994-05-11 2005-08-16 Jes Olesen Uso de depuradores, inhibidores o antagonistas de no en el tratamiento de la migraña.
FR2722507B1 (fr) * 1994-07-12 1996-08-14 Rhone Poulenc Rorer Sa Adenovirus comportant un gene codant pour une no synthase
EP0843550A1 (de) * 1995-08-09 1998-05-27 Ontogen Corporation Stickstoffmonoxid-synthase hemmer
WO1998036730A2 (de) * 1997-02-21 1998-08-27 Beiersdorf Ag Zubereitungen für die behandlung von rosacea
IT1312537B1 (it) * 1999-04-16 2002-04-22 Euphar Group Srl Derivati del (-)- verbenone.
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
WO2018156917A1 (en) * 2017-02-23 2018-08-30 The Cleveland Clinic Foundation Anti-aging compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2395638A (en) * 1941-03-07 1946-02-26 Research Corp Hydroxylation of aromatic hydrocarbons
FR924M (de) * 1959-09-26 1961-11-13
US3758520A (en) * 1971-07-23 1973-09-11 C Beaudet Process for the preparation of beta-naphthoquinone semicarbazone
JPH037806A (ja) * 1989-06-05 1991-01-16 Masamoto Kaneko 廃棄物の処理方法及び装置

Also Published As

Publication number Publication date
EP0631776A1 (de) 1995-01-04
ES2154285T3 (es) 2001-04-01
CA2127214C (fr) 2004-10-26
CA2127214A1 (fr) 1995-01-03
HUT70507A (en) 1995-10-30
HU9401977D0 (en) 1994-09-28
EP0631776B1 (de) 2000-11-22
DE69426316T2 (de) 2001-05-03
RU94022756A (ru) 1996-09-10
ATE197668T1 (de) 2000-12-15
FR2707494B1 (fr) 1995-08-25
PT631776E (pt) 2001-05-31
FR2707494A1 (fr) 1995-01-20
JP3993647B2 (ja) 2007-10-17
RU2131246C1 (ru) 1999-06-10
HU214716B (hu) 1998-05-28
GR3035059T3 (en) 2001-03-30
DE69426316D1 (de) 2000-12-28
JPH07145129A (ja) 1995-06-06
US5478821A (en) 1995-12-26

Similar Documents

Publication Publication Date Title
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
MD1507F2 (en) Inhibitors, pharmaceutical composition on base thereof and process for HIV protease inhibition
DK0497816T3 (da) Behandling af HIV-infektioner og forbindelser anvendelige derved
DK0615458T3 (da) Fremgangsmåde til reduktion af infektioner relateret til medicinske anordninger
AU3242689A (en) Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii
DK97890D0 (da) Fremgangsmaade til fremstilling af mevalolactonanaloge
DK0590271T3 (da) 17beta-aryl- og 17beta-heterocyclyl-5alfa, 14beta-androstan-, androsten- og -androstadienderivater med aktivitet på det kardiovaskulære system, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK0397336T3 (da) Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2
FI102239B1 (fi) Mikrobiologisen kasvun estämiseen käyttökelpoinen 2-(tiosyanometyylitio)bentsotiatsolia ja 2,4,6-tribromifenolia sisältävä koostumus ja menetelmä mikro-organismien kasvun estämiseksi sen avulla
DE69426316D1 (de) Verwendung von Beta-Naphthochinonderivaten zur Beschleunigung der Proliferation der Endothelzellen und Inhibierung der NO-Synthasen
DK72289D0 (da) Cephemcarboxylsyreestere, deres fremstilling og anvendelse
FI891581A0 (fi) Peptidderivat.
AU2002213579A1 (en) Medicaments for treating dementia
NO944407D0 (no) Alkoholer som kalium-kanalåpnere og ved behandling av urin-inkontinens
GB2324528B (en) Cytostatic hydroxamic acid derivatives
SE8303136L (sv) Optiskt aktiva derivat av n-arylerat oxazolidinon-2, specifika och reversibla inhibitorer av monoaminoxydas av typ b, och deras framstellningssett
AU2566101A (en) Compounds and methods for the treatment of pain
DK0387712T3 (da) WS7622A-, B-, C- og D-stoffer, derivater deraf og fremgangsmåder til fremstilling deraf samt anvendelse deraf
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DE3772909D1 (de) 3-methylphthalimide.
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
DK31383D0 (da) Anvendelse som plantevaekstfaktorer af 0-phenylhydroxylamin og af visse derivater deraf
JPS572684A (en) Preparation of amylase inhibitor ai-b
DE3780080D1 (de) Coccidiozide mittel.
DE69110570D1 (de) Arzneimittel, enthaltend ein N6-substituiertes Adenosin-Derivat zur Behandlung von Hyperlipidämie oder Hypertriglyceridämie.